Evidence map›Paper›PMID 39387156›Full record

ArticleAngewandte Chemie (International ed. in English)2025

Electric-Field Catalysis on Carbon Nanotubes in Electromicrofluidic Reactors: Monoterpene Cyclizations.

Augustina Jozeliūnaitė, Shen-Yi Guo, Naomi Sakai, Stefan Matile

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Oriented Electric Fields─Universal Catalysts.Accounts of chemical research · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Augustina JozeliūnaitėDepartment of Organic Chemistry, University of Geneva, Geneva, Switzerland.
Shen-Yi GuoDepartment of Organic Chemistry, University of Geneva, Geneva, Switzerland.
Naomi SakaiDepartment of Organic Chemistry, University of Geneva, Geneva, Switzerland.
Stefan MatileDepartment of Organic Chemistry, University of Geneva, Geneva, Switzerland.ORCID https://orcid.org/0000-0002-8537-8349

Funding

National Centre of Competence in Research Molecular Systems Engineering 51NF40-205608Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 200020 204175Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung TMAG-2_209190University of Geneva
6 · The paper itself

Abstract

The control over the movement of electrons during chemical reactions with oriented external electric fields (OEEFs) has been predicted to offer a general approach to catalysis. Recently, we suggested that many problems to realize electric-field catalysis in practice under scalable bulk conditions could possibly be solved on multiwalled carbon nanotubes in electromicrofluidic reactors. Here, we selected monoterpene cyclizations to assess the scope of our system in organic synthesis. We report that electric-field catalysis can function by stabilizing both anionic and cationic transition states, depending on the orientation of the applied field. Moreover, electric-field catalysis can promote reactions which are barely accessible by general Brønsted and Lewis acids and field-free anion-π and cation-π interactions, and drive chemoselectivity toward intrinsically disfavored products without the need for pyrene interfacers attached to the substrate to prolong binding to the carbon nanotubes. Finally, interfacing with chiral organocatalysts is explored and evidence against contributions from redox chemistry is provided.

Indexed as

anion-π catalysiscarbon nanotubescation-π catalysiscyclizationsflow chemistryhydride shiftsmicrofluidicsOriented external electric fieldsterpenes

Identifiers

PMID39387156
PMCPMC11753599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.